Therapeutic drug monitoring in breast cancer therapy – LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum

Katharina Habler, Anne-Sophie Kalla, Michael Rychlik, Michael Vogeser, Daniel Teupser